8 04, 2016

Webcast Provides Perspective on Generic Imatinib

By |2020-07-09T15:58:49-04:00April 8th, 2016|Generics, GIST Education, Webcast|

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and GIST communities on March 18th entitled “Generic Imatinib: Gaining Perspective.”

10 02, 2016

Generic Imatinib Approved in the US for CML: What does it mean for GIST patients?

By |2019-09-23T11:28:24-04:00February 10th, 2016|Drug Treatment, Generics, Gleevec, News, Newsletter|

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), for CML (Chronic Myeloid Leukemia) was approved by the FDA after the Novartis patent expiration and will become available for the first time in the United States through Sun Pharmaceuticals.

18 01, 2016

Generics Resources

By |2019-09-23T11:24:29-04:00January 18th, 2016|

Helpful Links Apotex Launches Imatinib Tablets Generic Version of Novartis's Gleevec® with Patient Savings Card Program Novartis settles patent litigation on Gleevec® (imatinib mesylate) with Sun Pharma subsidiary Teva Announces Launch of Generic Gleevec® [...]

18 01, 2016

Generics TKI List

By |2019-09-23T11:24:56-04:00January 18th, 2016|

This list provides information of all generic TKIs available on the international markets on the product name, compound name (active ingredient), the name of the respective manufacturer and/or Marketing Authorization Holder (MAH). All information is based [...]

18 01, 2016

Generics

By |2019-09-23T11:25:27-04:00January 18th, 2016|

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec) originally  for CML (Chronic Myeloid Leukemia) has been approved by the FDA and became available for the first time in [...]

10 04, 2012

GIST FAQ’s

By |2020-10-21T15:41:35-04:00April 10th, 2012|

As in many rare cancers, having GIST often comes with far more questions than answers. The good news is that there has been a great deal learned about this cancer in the years since [...]

Need a new search?

If you didn't find what you were looking for, try a new search!

Go to Top